Willow Biosciences, Inc.

Check out an interview with our CEO, Chris Savile, where he provides some additional information on our Q2 results and outlook for the rest of 2024.

Please see our Q2 2024 financial results and corporate update.

We're excited to announce another new, large partnership that extends our technology platform to the production of biopesticides. This partnership brings both significant near-term R&D revenue and long-term upside.

Sorry, we're a bit behind on our posts. If you haven't read it yet, here's the recent PR announcing our large partnership with Laurus Labs.

Check out our 2022 recap and 2023 outlook.

Check out our most recent press release providing an update on our business and operations.

@WillowBio is very pleased to announce the signing of a Master Service Agreement with @KalsecInc for the development and manufacture of functional food ingredients, using the FutureGrown precision fermentation platform.

Join @WillowBio at 2pm EST on Thursday, November 10th for an Investor Presentation Webcast, and live Q&A session.

Willow has incorporated Inscripta's Onyx Genome Engineering Platform into its strain engineering workflows. Read more in our press release here. #FutureGrown #SynBio

Willow expands its portfolio with a new partnered pharmaceutical project demonstrating the wide array of opportunities accessible to Willow’s #FutureGrown technology platform.

RT @aharmantas: $WLLW Willow Biosciences strikes manufacturing partnership to boost production capacity for its cannabinoid products @WillowBio $CANSF #WLLW #CANSF

@WillowBio is pleased to announce Q3 results, and the appointment of Dr. Peter Seufer-Wasserthal as President and CEO.

@willowbio announces the addition of a new pure, consistent and sustainable functional ingredient; FutureGrown Astaxanthin. This carotenoid is used in animal feed as a pigment, and in cosmetics & nutraceuticals for its powerful antioxidant properties.

Biden’s executive order advancing biotech signals a promising future for the industry. At Willow, we have been working towards providing pure, consistent & sustainable functional ingredients since 2019, and we are proud to be a part of the Bio Revolution.

Check out our recent press release providing an update on CBG including manufacturing, safety and IP

Willow Biosciences completes Q2 with significant progress to its operational platform, leadership and liquidity. Read more in our press release. #FutureGrown #SynBio #Biosynthesis

Next week, Willow is attending IFT first, the premier B2B #foodtech expo in Chicago. Looking forward to discussing functional ingredients and Willow's own sustainable #FutureGrown platform. #biotech #natural #SynBio

Check out our recent press release announcing our expanding fermentation network and progress on our #FutureGrown CBG GRAS determination

Come visit us at New York Society of Cosmetic Chemists Supplier’s Day, May 3-4 in New York City’s Javits Convention Center – booth 459

Fresh from a great show at In-Cosmetics Paris, Willow is going to be exhibiting at The CBD Show in London on Apr 22-23. Come see our own Dr. Simon Hickling giving a talk on Willow's #FutureGrown fermentation technology platform on Saturday's seminar agenda.